VAERS reports by lot

Merck HPV lot U031056: VAERS reports

29 VAERS reports list lot U031056 as a Merck HPV vaccine, received between 2022-09-09 and 2024-10-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
0%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological627%
Injection-site / Local reaction627%
Cardiac / Cardiovascular314%
Dermatological (non-injection-site)314%
Allergic / Anaphylactic15%
Respiratory15%
Gastrointestinal15%
Musculoskeletal15%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York7
Washington2
Colorado2
Texas2
Georgia2
Florida2
Ohio2
Pennsylvania1
Iowa1
Kansas1
Indiana1
Mississippi1

Reports by month received

2022-092
2022-104
2022-112
2022-122
2023-012
2023-021
2023-034
2023-041
2023-056
2023-071
2023-112
2024-051
2024-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.